0001209191-24-001165.txt : 20240108
0001209191-24-001165.hdr.sgml : 20240108
20240108165043
ACCESSION NUMBER: 0001209191-24-001165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shook David
CENTRAL INDEX KEY: 0001959742
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 24520827
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (925) 407-1049
MAIL ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-04
0
0001787400
Nkarta, Inc.
NKTX
0001959742
Shook David
C/O NKARTA, INC.
1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
0
Common Stock
2024-01-04
4
A
0
56000
0.00
A
118532
D
Stock Option (right to buy)
6.01
2024-01-04
4
A
0
112500
0.00
A
2034-01-03
Common Stock
112500
112500
D
Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2023.
This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2024.
/s/ Alicia Hager, as Attorney-in-Fact
2024-01-08